Claims
- 1. A method of lowering fasting plasma glucose and hemoglobin A1c in a patient in need thereof, the method comprising administering to the patient a therapeutically effective amount of an aliphatic amine polymer or a pharmaceutically acceptable salt thereof.
- 2. A method of claim 1 wherein the aliphatic amine polymer or pharmaceutically acceptable salt thereof is co-administered with a statin.
- 3. A method of claim 1 wherein the aliphatic amine polymer is colesevelam HC1.
- 4. A method of claim 2 wherein the aliphatic amine polymer is colesevelam HC1.
- 5. A method of claim 3 wherein the amount of colesevelam HC1 is from about 2.3 grams to about 4.5 grams per day.
- 6. A method of claim 4 wherein the amount of colesevelam HC1 is from about 2.3 grams to about 4.5 grams per day;
- 7. A method of claim 3 wherein the statin is atorvastatin, simvastatin or lovastatin.
- 8. A method of claim 4 wherein the statin is atorvastatin, simvastatin or lovastatin.
- 9. A method of claim 5 wherein the statin is atorvastatin, simvastatin or lovastatin.
- 10. A method of claim 6 wherein the statin is atorvastatin, simvastatin or lovastatin.
- 11. A method of lowering fasting plasma glucose in a patient in need thereof, the method comprising administering to the patient a therapeutically effective amount of an aliphatic amine polymer or a pharmaceutically acceptable salt thereof.
- 12. A method of claim 11 wherein the aliphatic amine polymer or pharmaceutically acceptable salt thereof is co-administered with a statin.
- 13. A method of claim 11 wherein the aliphatic amine polymer is colesevelam HC1.
- 14. A method of claim 12 wherein the aliphatic amine polymer is colesevelam HC1.
- 15. A method of claim 13 wherein the amount of colesevelam HC1 is from about 2.3 grams to about 4.5 grams per day;
- 16. A method of claim 14 wherein the amount of colesevelam HC1 is from about 2.3 grams to about 4.5 grams per day;
- 17. A method of claim 13 wherein the statin is atorvastatin, simvastatin or lovastatin.
- 18. A method of claim 14 wherein the statin is atorvastatin, simvastatin or lovastatin.
- 19. A method of claim 15 wherein the statin is atorvastatin, simvastatin or lovastatin.
- 20. A method of claim 16 wherein the statin is atorvastatin, simvastatin or lovastatin.
- 21. A method of lowering hemoglobin A1c in a patient in need thereof, said method comprising administering to the patient a therapeutically effective amount of an aliphatic amine polymer or a pharmaceutically acceptable salt thereof.
- 22. A method of claim 21 wherein the aliphatic amine polymer or pharmaceutically acceptable salt thereof is co-administered with a statin.
- 23. A method of claim 21 wherein the aliphatic amine polymer is colesevelam HC1.
- 24. A method of claim 22 wherein the aliphatic amine polymer is colesevelam HC1.
- 25. A method of claim 23 wherein the amount of colesevelam HC1 is from about 2.3 grams to about 4.5 grams per day.
- 26. A method of claim 24 wherein the amount of colesevelam HC1 is from about 2.3 grams to about 4.5 grams per day.
- 27. A method of claim 23 wherein the statin is atorvastatin, simvastatin or lovastatin.
- 28. A method of claim 24 wherein the statin is atorvastatin, simvastatin or lovastatin.
- 29. A method of claim 25 wherein the statin is atorvastatin, simvastatin or lovastatin.
- 30. A method of claim 26 wherein the statin is atorvastatin, simvastatin or lovastatin.
STATEMENT OF RELATED APPLICATION
[0001] This application claims the benefit of priority of U.S. Provisional Application No. 60/359,890, filed on Feb. 26, 2002.
[0002] The entire teaching of the above-referenced application is incorporated herein by reference.
Provisional Applications (1)
|
Number |
Date |
Country |
|
60359890 |
Feb 2002 |
US |